$0.00
(0.00%
) Quote details
USD
( 0.00%
At Close (As of Jan 1, 1970)
$7.73M
Market Cap
0.0101
P/E Ratio
401.62
EPS
$330.00
52 Week High
$2.78
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
NuCana PLC is a clinical-stage biopharmaceutical company based in Edinburgh, UK, focused on transforming cancer treatment through its proprietary ProTide technology platform. This cutting-edge approach aims to enhance the efficacy and safety of existing chemotherapy agents, targeting significant unmet needs within oncology. Currently, NuCana's lead candidates are in clinical trials for several malignancies, such as colorectal and pancreatic cancer, demonstrating the company's commitment to advanced research and improving patient outcomes. With a robust pipeline and a dedicated focus on innovation, NuCana is well-positioned to make a significant impact in the dynamic field of cancer therapeutics.
LPTX
NVDA
CGC
WOK
PLUG
ASST
TSLA
AVGO
INTC
TLRY
KIND
IQ
TNYA
KAVL
ORCL
SOFI
ADAP
DNN
F
PLTD
AAL
HPE
KVUE
WULF
MARA
PLTR
VALE
BYND
BAC
RR
APLT
SNAP
CLSK
BITF
GOOGL
IRBT
IREN
IVP
PFE
RIG
RKLB
QBTS
NIO
CIFR
NFLX
ASBP
AMD
GRAB
SMR
MTSR
FI
WBD
HOOD
HL
JBLU
APLD
CAN
SOUN
CDE
T
AG
BTBT
HBAN
DVLT
NOK
EOSE
GOOG
LPTX
NVDA
CGC
WOK
PLUG
ASST
TSLA
AVGO
INTC
TLRY
KIND
IQ
TNYA
KAVL
ORCL
SOFI
ADAP
DNN
F
PLTD
AAL
HPE
KVUE
WULF
MARA
PLTR
VALE
BYND
BAC
RR
APLT
SNAP
CLSK
BITF
GOOGL
IRBT
IREN
IVP
PFE
RIG
RKLB
QBTS
NIO
CIFR
NFLX
ASBP
AMD
GRAB
SMR
MTSR
FI
WBD
HOOD
HL
JBLU
APLD
CAN
SOUN
CDE
T
AG
BTBT
HBAN
DVLT
NOK
EOSE
GOOG